Reply letter- critical comments on the impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study
Clin Nutr
.
2021 Nov;40(11):5521-5522.
doi: 10.1016/j.clnu.2021.09.011.
Epub 2021 Sep 17.
Authors
Denise Mafra
1
,
Livia Alvarenga
2
,
Ludmila Cardozo
2
,
Peter Stenvinkel
3
,
Denis Fouque
4
Affiliations
1
Fluminense Federal University (UFF), Niterói, Brazil. Electronic address: dm@id.uff.br.
2
Fluminense Federal University (UFF), Niterói, Brazil.
3
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.
4
Department of Nephrology, Centre Hopitalier Lyon Sud, INSERM 1060, CENS, Université de Lyon, France.
PMID:
34656947
DOI:
10.1016/j.clnu.2021.09.011
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Curcumin*
Dietary Supplements
Double-Blind Method
Humans
Pilot Projects
Renal Dialysis
Transcription Factors
Substances
Transcription Factors
Curcumin